Controlled-release diethylpropion hydrochloride used in a program for weight reduction.
In a double-blind, placebo-controlled evaluation in obese adults given comparable dietary and exercise recommendations, controlled-release diethylpropion hydrochloride promoted significantly more weight loss than matching placebo. The mean reduction in 12 weeks was 15.9 lb (average 1.32 lb/week) for 12 patients taking diethylpropion hydrochloride, 10.0 lb (0.84 lb/week) for 13 taking placebo, and 12.2 lb for 13 taking drug for two four-week periods separated by four weeks of placebo (1.38 lb/week on active drug and 0.30 lb/week on placebo). Amphetamine-like side effects were virtually absent. Diethylpropion hydrochloride is an effective adjunct to caloric restriction in therapy of obesity.
D000293:Adolescent; D000328:Adult; D001835:Body Weight; D003692:Delayed-Action Preparations; D004038:Diet, Reducing; D004053:Diethylpropion / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D005082:Physical Exertion
D003692:Delayed-Action Preparations; D004053:Diethylpropion